VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.
ARX is a defense technology company that specializes in the development of autonomous unmanned systems for dual-use applications.
Sekoia.io develops a unified security platform aimed at enhancing the capabilities of security operations (SecOps) teams in combating cyber threats. The platform enables organizations to automatically identify and respond to significant incidents across their entire attack surface, leveraging integrated intelligence and real-time detection. By continuously analyzing emerging threats, Sekoia.io equips clients with the necessary strategies to stay updated and effectively address new challenges. Its approach allows security teams to manage the complexities of cybersecurity with improved speed and reliability, ultimately strengthening their overall security posture.
Coave Therapeutics specializes in developing gene therapies aimed at treating rare ocular and central nervous system diseases. The company focuses on innovative solutions for rare retinal disorders, utilizing a recombinant adeno-associated virus that substitutes the viral DNA with a functional copy of the PDE6B gene. This therapeutic approach involves injecting the corrected version of the protein between the photoreceptors and the retinal pigment epithelium, providing patients with effective treatment options for various eye conditions.
Planet A Foods is a company focused on producing cocoa-free chocolate made from natural ingredients. By utilizing traditional fermentation methods, the company aims to provide a sustainable alternative to traditional chocolate, allowing consumers to enjoy their chocolate cravings without the negative impacts associated with cocoa production. Planet A Foods emphasizes local food production with minimal environmental impact, striving to reduce carbon emissions and promote sustainable practices in the food industry.
The Exploration Company specializes in the development, manufacturing, and operation of modular and reusable spacecraft known as Nyx, which are intended for use in orbit around Earth and the Moon. These vehicles are designed to be refueled in space and incorporate environmentally friendly propellants. By offering an open-source operating system for Nyx, the company aims to democratize space exploration, making it more accessible to new entrants in the field. The Exploration Company focuses on providing cost-effective solutions for in-space experiments, allowing participants to engage in space exploration at a fraction of the cost associated with traditional platforms like the International Space Station.
Qantev operates an AI-driven health claims platform designed for health and life insurance companies. The platform utilizes a proprietary algorithm to enhance the configuration of provider networks and identify optimal participants, thereby assisting insurers in minimizing claims leakage. By leveraging historical claims data, Qantev's technology empowers health insurance teams to gain valuable insights, facilitating data-driven decision-making and the development of effective business strategies. This innovative approach aims to improve efficiency and accuracy in claims operations across the global insurance market.
Carbyon is a Netherlands-based company specializing in direct air capture (DAC) technologies that filter carbon dioxide (CO2) from ambient air. Its innovative "fast-swing" technology purifies CO2, making it suitable for various applications, including the production of kerosene for aircraft. By enabling the fossil fuel industry to repurpose existing storage and transportation infrastructure for renewable hydrocarbons, Carbyon supports the transition from fossil hydrocarbons to alternative energy carriers, such as batteries and hydrogen. This approach not only aids in reducing greenhouse gas emissions but also facilitates significant transformations in energy systems and transportation networks.
Unseenlabs is a French company based in Rennes, founded in 2015, that specializes in marine surveillance services utilizing satellite technology. The company develops spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels globally. By launching satellites equipped to detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs can identify vessels even if they disable their Automatic Identification System beacon. This capability allows clients to monitor maritime activities and locate boats engaged in illegal operations, such as illegal fishing, degassing, and maritime piracy. Unseenlabs provides comprehensive solutions that encompass satellite design and launch, ensuring effective maritime monitoring from space.
Erneuerbare Energien Fabrik is an energy company that focuses on wind energy, photovoltaics and storage technologies with AI software.
GEEV is a mobile application that facilitates the donation and collection of various objects among its users, promoting a collaborative anti-waste initiative. It allows members to either give away items they no longer need or to obtain free objects from others, thereby encouraging sustainable practices and reducing waste. The platform includes features that enable users to communicate easily, arrange meetings, and effectively exchange items, fostering a community-driven approach to sharing resources. By connecting individuals who wish to donate with those seeking to obtain, GEEV aims to give a second life to usable items while minimizing environmental impact.
Planet A Foods is a company focused on producing cocoa-free chocolate made from natural ingredients. By utilizing traditional fermentation methods, the company aims to provide a sustainable alternative to traditional chocolate, allowing consumers to enjoy their chocolate cravings without the negative impacts associated with cocoa production. Planet A Foods emphasizes local food production with minimal environmental impact, striving to reduce carbon emissions and promote sustainable practices in the food industry.
Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.
Quantum system develops manufactures and sells unmanned aerial systems, which provide aerial intelligence to commercial and governmental clients around the world.
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
PeopleSpheres is a Paris-based company that specializes in providing human resources management software solutions. Founded in 2010 and formerly known as NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. Recognizing a gap in the market for tailored HR management solutions, PeopleSpheres developed a customizable and scalable platform designed to meet the diverse needs of businesses. The company collaborates with leading national HR service providers to better serve American enterprises, ensuring that its offerings are both suitable and sustainable for a wide range of clients. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS.
Sekoia.io develops a unified security platform aimed at enhancing the capabilities of security operations (SecOps) teams in combating cyber threats. The platform enables organizations to automatically identify and respond to significant incidents across their entire attack surface, leveraging integrated intelligence and real-time detection. By continuously analyzing emerging threats, Sekoia.io equips clients with the necessary strategies to stay updated and effectively address new challenges. Its approach allows security teams to manage the complexities of cybersecurity with improved speed and reliability, ultimately strengthening their overall security posture.
DiogenX is a preclinical stage biotech company based in Marseille, France, with research labs in Nice. Founded in 2019, the company specializes in developing therapeutic solutions for diabetic patients, focusing on pancreatic beta-cell modulators for the treatment of Type 1 and Type 2 diabetes. DiogenX aims to create a candidate molecule that regenerates insulin-producing pancreatic cells, potentially improving the quality of life and survival rates for individuals with diabetes. The innovative therapy is based on research conducted in the laboratory of Dr. Patrick Collombat, which positions DiogenX as a pioneer in the development of beta-cell regeneration treatments for diabetes.
Iktos is a French company focused on artificial intelligence and robotic solutions for medicinal chemistry and drug design. It offers a proprietary generative AI technology that optimizes molecule design for small molecule discovery projects, significantly enhancing productivity in pharmaceutical research and development. Iktos provides its innovative solutions through its SaaS platforms, Makya™ for generative drug design and Spaya™ for retrosynthesis, while also engaging in strategic partnerships with pharmaceutical companies to accelerate drug discovery. Additionally, Iktos has developed an AI-driven synthesis automation platform, Iktos Robotics, which expedites the Design-Make-Test-Analyze cycle in drug development. The company is also advancing its own pipeline of drug candidates aimed at oncology and autoimmune diseases. In March 2023, Iktos secured a significant financing round, and in July 2024, it enhanced its capabilities by acquiring Synsight, which adds a biology platform for discovering drugs targeting Protein-Protein and RNA-Protein interactions.
The Exploration Company specializes in the development, manufacturing, and operation of modular and reusable spacecraft known as Nyx, which are intended for use in orbit around Earth and the Moon. These vehicles are designed to be refueled in space and incorporate environmentally friendly propellants. By offering an open-source operating system for Nyx, the company aims to democratize space exploration, making it more accessible to new entrants in the field. The Exploration Company focuses on providing cost-effective solutions for in-space experiments, allowing participants to engage in space exploration at a fraction of the cost associated with traditional platforms like the International Space Station.
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.
Opensee, is a Paris-based fintech that is helping financial institutions turn their big data challenges into competitive advantage and unlock vital business-user-led opportunities. Opensee, formerly ICA, was started by a team of financial industry and technology experts frustrated at not being able to find a simple Big Data analytics solution that would enable them to easily and efficiently dive deeper into all their data and perform what-if-analysis on the hundreds of billions of data points they were handling - so they built their own. With Opensee, for the first time, financial institutions’ business users can directly harness 100% of their vast quantities of data instantly on demand. Opensee empowers data divers to analyse deeper and faster. DISCOVER HOW WE HELP FINANCIAL INSTITUTIONS: - Manage RISK IN CAPITAL MARKETS more efficiently and proactively - Manage COMMERCIAL & RETAIL BANKING resources and regulatory reports with consistency, speed and granularity - Leverage your TRANSACTION DATA to improve your market intelligence and execution process
Dust Mobile is a mobile operator based in Brussels, Belgium, specializing in cyber security solutions for voice, text, and data communications. Established in 2017, the company focuses on protecting its clients from threats associated with cellular network signaling protocols across various technologies, including 2G, 3G, 4G LTE, and 5G. Dust Mobile offers comprehensive services that include encryption for voice, SMS, and data communications, as well as cyber security for mobile networks and transmission. Its mission is to provide secure and resilient mobile communication services to businesses, critical operations, and organizations worldwide, especially for individuals and connected devices that are vulnerable to cyber-attacks. Founded by a team with extensive expertise in defense, security, electronic warfare, and telecommunications, Dust Mobile aims to defend critical communications against an evolving landscape of cyber threats.
Qantev operates an AI-driven health claims platform designed for health and life insurance companies. The platform utilizes a proprietary algorithm to enhance the configuration of provider networks and identify optimal participants, thereby assisting insurers in minimizing claims leakage. By leveraging historical claims data, Qantev's technology empowers health insurance teams to gain valuable insights, facilitating data-driven decision-making and the development of effective business strategies. This innovative approach aims to improve efficiency and accuracy in claims operations across the global insurance market.
Gourmey is a cultivated meat company based in Paris, France, founded in 2019. It specializes in producing ethical foie gras derived from duck cells, offering a sustainable alternative to traditional methods that involve force-feeding and slaughter. By cultivating animal cells in a controlled laboratory environment, Gourmey creates meat products that prioritize health, environmental sustainability, and animal welfare. The company aims to provide delicious meat options for consumers who are conscious of their choices and seek innovative solutions in the food industry.
Ternoa is a blockchain technology company founded in 2013 and based in Biarritz, France. The company specializes in secure and anonymous data transfer, eliminating the need for intermediaries. Its innovative technology enables users to access digital transmission globally, utilizing decentralized storage providers to maintain the long-term integrity of encrypted and segmented data. Ternoa empowers users to protect the data contained within non-fungible tokens (NFTs) through multi-party cryptography, ensuring enhanced security and privacy in digital communications.
WhiteLab Genomics is a biotechnology company that has developed a proprietary platform utilizing graph knowledge technology and machine learning to support the discovery and design of new genomic therapies. By providing a comprehensive database, the platform allows scientists to conduct detailed analyses of various datasets, facilitating solutions to critical scientific and technical challenges. These include optimizing plasmid and vector design, assessing genotoxicity, and identifying effective experimental protocols for both in vivo and in vitro applications. WhiteLab Genomics focuses on guiding clients through the in-silico development phases, enabling them to efficiently create target vectors and payloads. This streamlined approach not only saves time but also accelerates the delivery of innovative genomic therapies to patients.
Qubit Pharmaceuticals is a Paris-based company founded in 2020 that specializes in drug discovery technology. Established through collaboration among notable institutions such as CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, it draws on over 20 years of research and development recognized by prestigious awards. The company has developed a drug discovery simulation platform that aims to reduce both the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform conducts virtual screening and visualization to identify promising drug candidates. This innovative approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
Therapixel develops and commercializes AI-based software for breast cancer detection and characterization
Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-Allâ„¢ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-Allâ„¢ is able to address difficult GPCRs such as orphan and peptidic GPCRs.
TagEnergy is a clean energy enterprise for a new cycle in the renewable energy industry. It was formed in 2019 to accelerate the energy transition by developing and investing in competitive and clean power stations in order to compete directly and actively on the energy markets. Renewables have now become the main source of energy able to provide both social responsibility and price efficiency, and we are delivering this in the countries where we have established our activity. TagEnergy is operated by a highly-experienced team of manager-shareholders. Its operations span the renewables value chain, from development, financing, construction and asset management of wind, solar and storage projects, to commercialisation of its competitive energy. TagEnergy has developed a portfolio of 2.7GW in the UK, Australia, Spain, Portugal and France, and intends to drive the pace of transition through projects that deliver reliable energy affordably, and at scale.
Skillup has designed the new @Tripadvisor for professional trainings hosting over 20k trainings and 50k reviews. It aims at helping HR services to find the adequate trainig for employees.
Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGS has had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
AlgoTherapeutix is a biotechnology company focused on developing topical treatments for complex pain conditions, particularly those that are difficult to treat and lack proven therapies. The organization targets damaged nerve fibers in the skin, aiming to provide pain relief without the systemic side effects associated with oral medications. Currently, AlgoTherapeutix's lead product, ATX01, has received FDA approval to enter Phase 2 clinical trials for chemotherapy-induced peripheral neuropathy, a painful condition resulting from cancer treatment. Additionally, the company is exploring the potential of its treatments for erythromelalgia, a rare and debilitating disorder characterized by severe pain. Through its innovative approach, AlgoTherapeutix seeks to address the specific needs of patients suffering from these challenging conditions.
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.
Coave Therapeutics specializes in developing gene therapies aimed at treating rare ocular and central nervous system diseases. The company focuses on innovative solutions for rare retinal disorders, utilizing a recombinant adeno-associated virus that substitutes the viral DNA with a functional copy of the PDE6B gene. This therapeutic approach involves injecting the corrected version of the protein between the photoreceptors and the retinal pigment epithelium, providing patients with effective treatment options for various eye conditions.
Prima Vital provides financing advice and assistance, delivery and installation of safety equipment, after-sales service, and warranty and maintenance of installations. Their customers' inquiries are addressed through phone, email, and online applications.
Ilmatar is a project-oriented integrator in the renewable energy sector, primarily focusing on the development, construction, and operation of onshore wind farms. The company aims to build 1 GW of new wind power capacity in Finland over the next five years, significantly contributing to the reduction of carbon dioxide emissions and promoting a cleaner energy future. Ilmatar identifies, develops, finances, constructs, and operates renewable energy sites while also exploring new carbon-neutral technologies. The company engages in long-term Power Purchase Agreements (PPAs) to provide stable energy supplies. With a commitment to sustainability, Ilmatar collaborates with a network of domestic and international partners, including Omnes Capital and EDF Renewables, while local companies handle project development and operations.
Unseenlabs is a French company based in Rennes, founded in 2015, that specializes in marine surveillance services utilizing satellite technology. The company develops spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels globally. By launching satellites equipped to detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs can identify vessels even if they disable their Automatic Identification System beacon. This capability allows clients to monitor maritime activities and locate boats engaged in illegal operations, such as illegal fishing, degassing, and maritime piracy. Unseenlabs provides comprehensive solutions that encompass satellite design and launch, ensuring effective maritime monitoring from space.
PeopleSpheres is a Paris-based company that specializes in providing human resources management software solutions. Founded in 2010 and formerly known as NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. Recognizing a gap in the market for tailored HR management solutions, PeopleSpheres developed a customizable and scalable platform designed to meet the diverse needs of businesses. The company collaborates with leading national HR service providers to better serve American enterprises, ensuring that its offerings are both suitable and sustainable for a wide range of clients. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS.
Elistair designs and manufactures tethered drone systems, offering extended flight times, increased safety and secured high-speed data transfer, for persistent surveillance and communications. The company's products are deployed by police forces, public safety departments, private security companies and government on over 30 countries. Elistair has won several awards in Europe and in the US, acknowledging Elistair as a fast-growing top-innovative company. Elistair is proud to be the recipient of the 2016 Technology Innovation Award from Frost & Sullivan.
Artifakt is a developer of cloud application tools that streamline the deployment, management, and operation of web projects on modern cloud infrastructures. The company's solutions allow digital teams to autonomously deploy and maintain their web applications, significantly reducing the complexity and time involved in cloud deployment. By enabling developers to configure environments quickly and automate various processes, Artifakt empowers them to concentrate on writing, testing, and enhancing their code. This focus ultimately allows developers to return to their core passion of building innovative solutions.
AgomAb Therapeutics N.V., based in Gent, Belgium, focuses on developing innovative therapies using anti-MET antibodies for treating various diseases. The company specializes in creating agonistic monoclonal antibodies, known as agomAbs, which aim to stimulate molecular and cellular repair mechanisms to regenerate damaged tissues. This approach has the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative conditions. AgomAb is committed to exploring biologically validated pathways, particularly Transforming Growth Factor β and Hepatocyte Growth Factor, and is equipped with expertise in organ-specific small molecules and high-affinity antibodies. With a diversified clinical pipeline targeting multiple fibrotic conditions and comprehensive research and development capabilities, AgomAb Therapeutics is well-positioned in the therapeutic landscape.
BIZAY operates a digital marketplace that specializes in customizable products, catering to a diverse range of customers across Europe and the Americas. The company offers the world's largest catalogue of customizable items, allowing local manufacturers, brands, and wholesalers to deliver personalized products efficiently. Its platform targets various customer segments, including B2B2C businesses, small and medium-sized enterprises, and major brands seeking customized solutions. BIZAY’s extensive offerings encompass promotional items, packaging, home and garden goods, fashion products, and beauty items. The company emphasizes sustainability and social responsibility by collaborating with partners focused on inclusion and utilizing recycled materials in production. BIZAY employs advanced supply-chain optimization technologies to significantly reduce production costs, empowering clients to enhance their marketing strategies through innovative customization options.
AlgoTherapeutix is a biotechnology company focused on developing topical treatments for complex pain conditions, particularly those that are difficult to treat and lack proven therapies. The organization targets damaged nerve fibers in the skin, aiming to provide pain relief without the systemic side effects associated with oral medications. Currently, AlgoTherapeutix's lead product, ATX01, has received FDA approval to enter Phase 2 clinical trials for chemotherapy-induced peripheral neuropathy, a painful condition resulting from cancer treatment. Additionally, the company is exploring the potential of its treatments for erythromelalgia, a rare and debilitating disorder characterized by severe pain. Through its innovative approach, AlgoTherapeutix seeks to address the specific needs of patients suffering from these challenging conditions.
Power Capital Renewable Energy Limited, founded in 2011 and based in Dublin, Ireland, focuses on the development, operation, and management of large-scale photovoltaic solar farms. The company specializes in all four stages of a solar asset's life cycle, including design, development, financing, construction, and operation. By acquiring and managing utility-scale solar parks, Power Capital aims to provide clean and reliable energy, contributing to the sustainability of the renewable energy sector. Their commitment to delivering competitive and sustainable energy solutions positions them as a significant player in the renewable energy market.
Biosyl SAS is a holding company based in Cosne-Cours-sur-Loire, France, founded in 2010. Through its subsidiary, the company specializes in the production of wood pallets for domestic stoves and pallet boilers. Biosyl focuses on transforming waste and wood waste into energy, specifically low-emission wood pellets. The company operates a pellet production plant that processes logs and has the capacity to produce over one hundred thousand tons of pellets annually. This production not only supports local coppice wood recovery but also enables customers to reduce their carbon footprint by utilizing energy derived from low CO2 emissions.
Sekoia.io develops a unified security platform aimed at enhancing the capabilities of security operations (SecOps) teams in combating cyber threats. The platform enables organizations to automatically identify and respond to significant incidents across their entire attack surface, leveraging integrated intelligence and real-time detection. By continuously analyzing emerging threats, Sekoia.io equips clients with the necessary strategies to stay updated and effectively address new challenges. Its approach allows security teams to manage the complexities of cybersecurity with improved speed and reliability, ultimately strengthening their overall security posture.
AB Tasty is a software company that specializes in experimentation, personalization, and product optimization for marketers and product teams. Founded in 2009 and headquartered in Paris, France, AB Tasty provides a cloud-based platform that enables businesses to enhance their digital assets across various industries, including e-commerce, retail, travel, luxury, and financial services. The platform offers a comprehensive suite of tools for conversion rate optimization, including A/B testing, split testing, and multivariate testing, allowing teams to modify web pages and create new designs. By helping marketing, product, and technical teams understand user behavior and engage effectively with website and mobile visitors, AB Tasty aims to convert these visitors into customers, subscribers, and leads while driving overall business growth.
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
Biofutur is a network of medical biology analysis laboratories primarily located in France. The organization provides a wide array of services, including medical consultations, hematology, allergology, immunoassays, and embryo transfer, among other related offerings. By focusing on these diverse medical services, Biofutur aims to meet the diagnostic and analytical needs of patients and healthcare professionals in the region.
Dust Mobile is a mobile operator based in Brussels, Belgium, specializing in cyber security solutions for voice, text, and data communications. Established in 2017, the company focuses on protecting its clients from threats associated with cellular network signaling protocols across various technologies, including 2G, 3G, 4G LTE, and 5G. Dust Mobile offers comprehensive services that include encryption for voice, SMS, and data communications, as well as cyber security for mobile networks and transmission. Its mission is to provide secure and resilient mobile communication services to businesses, critical operations, and organizations worldwide, especially for individuals and connected devices that are vulnerable to cyber-attacks. Founded by a team with extensive expertise in defense, security, electronic warfare, and telecommunications, Dust Mobile aims to defend critical communications against an evolving landscape of cyber threats.
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.
SOLVIONIC is a company developing specialized chemistry in the field of ionic liquids. As part of sustainable chemistry, SOLVIONIC uses an innovative technology which consists in designing chemical processes as a whole to use less energy, fewer raw materials, and to generate less waste.
Biosyl SAS is a holding company based in Cosne-Cours-sur-Loire, France, founded in 2010. Through its subsidiary, the company specializes in the production of wood pallets for domestic stoves and pallet boilers. Biosyl focuses on transforming waste and wood waste into energy, specifically low-emission wood pellets. The company operates a pellet production plant that processes logs and has the capacity to produce over one hundred thousand tons of pellets annually. This production not only supports local coppice wood recovery but also enables customers to reduce their carbon footprint by utilizing energy derived from low CO2 emissions.
Newronika is a company focused on restoring brain and body functions through innovative neuro-modulation technologies. It develops therapeutic devices that utilize a retro-activity system to record brain activity and modulate neuro-stimulation. By collecting, analyzing, and interpreting bio-signals, Newronika enables patients to receive timely stimulation, allowing them to engage in normal daily activities and enhance their quality of life. As a spin-off from prominent Italian research institutions, including the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika benefits from a multidisciplinary team of experts in various fields such as neuroscience, neurophysiology, biomedical engineering, and neuropsychology.
Wizaplace is a software as a service (SaaS) platform based in Lyon, France, that specializes in the creation and management of various types of marketplaces, including B2C, B2B, and C2C projects, as well as tailored service marketplaces. Founded in 2012, the platform provides an all-in-one solution that integrates essential functions for building and managing marketplaces in a single environment. It features a comprehensive back office for administrators and sellers, alongside a user-friendly front office for clients. Wizaplace aims to democratize the marketplace model by offering customizable options, allowing e-retailers to efficiently develop their e-commerce platforms with ease.
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.
SPHEREA specializes in the design and production of modular testing solutions for various electrical applications, catering to manufacturers, equipment suppliers, integrators, and rail operators. The company offers a range of products including model-based testing systems, field test equipment, wiring testers, and assisted maintenance and repair solutions. SPHEREA's expertise spans the entire life cycle of complex electronic, microwave, optronic, and mechatronic systems, serving critical sectors such as civil aeronautics, defense, energy, and rail both in France and internationally.
Bankin' is the Best Mobile Money Manager. Bankin' app makes money management super easy. At Bankin', they believe that money management must be simple, transparent and efficient so you can focus on what really matters to you. Their mission is to bring innovation and technology together to offer you the best solution to guide you every day. They are the leader in Europe: you are more than 1.5 million to trust us in France, in England, in Spain, and in Germany. They are the only company independent of banks in Europe. It is something they feel very strongly about because it allows us to provide better guidance by always suggesting what's right for you.
NH TherAguix SAS is a clinical stage pharmaceutical company based in Villeurbanne, France, focused on developing nanomedicines for cancer treatment, specifically utilizing radiotherapy. The company's lead product, AGuIX, is a theranostic nanoparticle designed to enhance the localization of solid tumors and improve the effectiveness of radiation therapy. AGuIX allows for the determination of optimal irradiation timing and is capable of treating radioresistant cancers while minimizing radiation exposure to healthy tissues, thereby reducing secondary effects. Founded in 2015, NH TherAguix is dedicated to advancing innovative solutions in cancer care through its pioneering research and development efforts.
AgomAb Therapeutics N.V., based in Gent, Belgium, focuses on developing innovative therapies using anti-MET antibodies for treating various diseases. The company specializes in creating agonistic monoclonal antibodies, known as agomAbs, which aim to stimulate molecular and cellular repair mechanisms to regenerate damaged tissues. This approach has the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative conditions. AgomAb is committed to exploring biologically validated pathways, particularly Transforming Growth Factor β and Hepatocyte Growth Factor, and is equipped with expertise in organ-specific small molecules and high-affinity antibodies. With a diversified clinical pipeline targeting multiple fibrotic conditions and comprehensive research and development capabilities, AgomAb Therapeutics is well-positioned in the therapeutic landscape.
Therapixel develops and commercializes AI-based software for breast cancer detection and characterization
Teach on Mars is Europe’s foremost mobile-led learning technology provider. Their solution helps today’s organisations connect people with the learning and the communities they need to do their jobs and live their lives better. Winner of numerous industry awards, Teach on Mars is recognised as European leader in the mobile learning space. Since its foundation in 2013, the company has delivered its solution to over 100 blue-chip clients, in 20+ languages across more than 60 countries throughout the globe, and today it has bases in Sophia-Antipolis, Paris, Milan and London. 60 Teach on Mars staff and an extensive worldwide network of 40+ content and technology partners collaborate to equip organisations with the toolset, mindset and skillset required to create their next-generation learning ecosystem. And because Teach on Mars takes its responsibility for the future of their planet seriously, it invests 1% of its revenues in education projects contributing directly to the UN Sustainable Development Goals.
BIZAY operates a digital marketplace that specializes in customizable products, catering to a diverse range of customers across Europe and the Americas. The company offers the world's largest catalogue of customizable items, allowing local manufacturers, brands, and wholesalers to deliver personalized products efficiently. Its platform targets various customer segments, including B2B2C businesses, small and medium-sized enterprises, and major brands seeking customized solutions. BIZAY’s extensive offerings encompass promotional items, packaging, home and garden goods, fashion products, and beauty items. The company emphasizes sustainability and social responsibility by collaborating with partners focused on inclusion and utilizing recycled materials in production. BIZAY employs advanced supply-chain optimization technologies to significantly reduce production costs, empowering clients to enhance their marketing strategies through innovative customization options.
ABMI is an engineering company that specializes in providing a range of solutions including design, IT infrastructure, robotics, Internet of Things (IoT), cloud computing, and cybersecurity. The company operates as a multi-specialist in a rapidly growing market, focusing on innovative technologies to meet the needs of its clients.
Captain Tortue is the European leader in direct selling women's ready-to-wear clothing. Every year, it designs around 330 models through its four brands: Trend (trendy collection, urban chic), Miss (classic and casual collection), Little Miss (children's collections, teenagers and small sizes) and Java (home wear comfort-casual).
Sentryo SAS specializes in cybersecurity and situational awareness solutions tailored for industrial networks and the Internet of Things. Founded in 2014 and headquartered in Charbonnières-les-Bains, France, the company focuses on enhancing the resilience and safety of industrial operations by providing continuous visibility over Industrial Control Systems (ICS) and SCADA infrastructures. Sentryo's flagship product, ICS CyberVision, empowers control engineers to monitor all equipment connected to industrial networks, identifying vulnerabilities and enabling informed decision-making to maintain system integrity. The company's solutions integrate artificial intelligence and machine learning to deliver real-time insights, analyze alarms, and enhance infrastructure security, thereby helping corporations mitigate the risks of cyberattacks. As of 2019, Sentryo operates as a subsidiary of Cisco Systems, Inc.
Intersec is a global leader in telecom metadata and location intelligence solutions, headquartered in France. The company provides advanced streaming analytics software that enables organizations to analyze vast amounts of data in real time. With a client base of 90 organizations across 40 countries, Intersec's solutions assist governments and telecommunications companies in harnessing data to drive revenue and improve public safety, including efficient emergency alerts. The company specializes in location intelligence, spatial computing, and telecom data monetization, and is recognized for its commitment to privacy and regulatory compliance. Intersec’s technology supports nearly one billion connected devices and aims to enhance organizational understanding of customer experiences, population movements, and transactional data.
GEEV is a mobile application that facilitates the donation and collection of various objects among its users, promoting a collaborative anti-waste initiative. It allows members to either give away items they no longer need or to obtain free objects from others, thereby encouraging sustainable practices and reducing waste. The platform includes features that enable users to communicate easily, arrange meetings, and effectively exchange items, fostering a community-driven approach to sharing resources. By connecting individuals who wish to donate with those seeking to obtain, GEEV aims to give a second life to usable items while minimizing environmental impact.
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing novel treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating antibacterial resistance-breakers that can restore the efficacy of existing antibiotics. Its key innovation includes inhibitors of bacterial metalloenzymes, specifically Metallo ß-lactamases (MBLs), which are designed to be used in combination with carbapenems to address significant treatment gaps in drug-resistant nosocomial infections. Antabio aims to provide health professionals with effective medicinal products to combat life-threatening respiratory infections, including carbapenem-resistant pneumonia and chronic pulmonary diseases. The company has received recognition for its research efforts, including a Wellcome Trust Seeding Drug Discovery Award.
Marquetis & Co, founded in 1996 and based in Boulogne Billancourt, France, operates as a comprehensive marketing and communications agency. Under the leadership of Virginie Massa and Evangelos Vatzias, the company has developed a range of services through its subsidiaries, including Marquetis One, Marquetis Connect, and Marquetis Call. Marquetis specializes in operational marketing, offering clients an integrated approach that encompasses global communication consulting and automated cross-channel marketing delivered in a SaaS format. The agency focuses on relational branding strategies, providing strategic, creative, digital, and customer contact advisory services. By utilizing predictive performance models, Marquetis aids clients in enhancing their brand strategies and achieving their marketing objectives.
Tiller Systems SAS is a provider of cloud-based point of sale (POS) software solutions tailored for restaurants and merchants. Founded in 2014 and headquartered in Paris, France, with additional offices in Barcelona and Milan, the company offers a comprehensive management tool that enables users to accept various types of payments, manage staff, and monitor inventory in real time. Its mobile POS application allows for efficient handling of both in-store and online orders from a single platform. Additionally, Tiller Systems provides a web dashboard for updating store catalogs, tracking sales and expenses, processing payroll, receiving low stock alerts, and accessing performance metrics. The e-store feature helps businesses engage with customers across multiple digital channels, enhancing their operational efficiency and decision-making capabilities.
The Mistral group markets an integrated software solution (ERP) dedicated to the market and the business of dealers, renters, resellers of agricultural equipment and construction equipment. The group consists of two entities, Mistral Informatique (publisher of software and mobility applications) and Mistral DataCenter (hosting and outsourcing services).
Nanomakers is a Paris-based company founded in 2010 that specializes in the design, manufacture, and marketing of silicon-based nanopowders. These patented, nano-scale powders are utilized to enhance the mechanical reinforcement of materials such as metal alloys and elastomers, as well as to improve the energy storage density of lithium-ion batteries through silicon-carbon composites in anodes. The company's nanopowders, including silicon carbide and silicon, significantly enhance the mechanical, thermal, and chemical performance of various industrial materials. Nanomakers serves multiple sectors, including semiconductors, energy storage, aeronautics, space, and automotive industries, by providing innovative solutions that contribute to advancements in technology and material performance.
Tilkee is a cloud-based application that enhances the efficiency of sales teams by tracking business proposals and optimizing follow-up with prospects. The platform allows users to easily upload sales documents and create branded online proposals. Once a unique link is generated for each prospect, Tilkee monitors their reading behavior, providing real-time notifications about who has engaged with the documents, which sections received the most attention, and the duration of their engagement. This data-driven approach helps sales professionals assess prospects' readiness to close deals, thereby increasing closing rates and improving overall marketing effectiveness.
Scality, Inc. specializes in software-defined storage solutions designed for active archives, content distribution, cloud services, and enterprise applications. Founded in 2009 and headquartered in San Francisco, California, with an additional office in Cambridge, Massachusetts, Scality is recognized for its flagship product, RING. This software-based storage system can scale to petabytes, providing high performance and robust data protection while integrating seamlessly with standard storage protocols such as NFS and S3. The RING serves a wide range of customers, including major media and telecommunications companies and leading operators across the US, Europe, and Japan. With its innovative approach, Scality aims to address the challenges of massive data storage and is committed to ensuring 100% availability for its users. The company was previously known as Bizanga Store Company until its rebranding in June 2010.
ForCity is a software-as-a-service company specializing in 4D urban simulation to aid decision-making in the development of smart cities. The firm has developed a decision support platform that enhances strategic planning and operational efficiency by integrating various datasets related to urban parameters such as energy consumption, water usage, real estate projects, and land availability. Using advanced 3D and 4D simulation techniques, the platform generates detailed reports that assist municipal managers in optimizing development strategies across areas like energy management, waste disposal, land use, and economic growth. This innovative approach enables municipalities to make informed decisions that contribute to sustainable urban development.
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.
Coave Therapeutics specializes in developing gene therapies aimed at treating rare ocular and central nervous system diseases. The company focuses on innovative solutions for rare retinal disorders, utilizing a recombinant adeno-associated virus that substitutes the viral DNA with a functional copy of the PDE6B gene. This therapeutic approach involves injecting the corrected version of the protein between the photoreceptors and the retinal pigment epithelium, providing patients with effective treatment options for various eye conditions.
Aero Negoce International is a fasteners distributor dedicated to the aerospace industry. Its main customers are aircraft manufacturers (e.g. Airbus, Dassault) and their main suppliers (e.g. Zodiac, Safran).
Groupe InCa is one of the regional leaders in the construction of built-to-order single-design detached homes, with three strong brands in Nouvelle Aquitaine: Maisons Clairlande, Les Demeures de la Côte d’Argent and Rouquié Constructions. The Group has a wide range of target customers, from first-time buyers to high-end customers.
Groupe InCa is one of the regional leaders in the construction of built-to-order single-design detached homes, with three strong brands in Nouvelle Aquitaine: Maisons Clairlande, Les Demeures de la Côte d’Argent and Rouquié Constructions. The Group has a wide range of target customers, from first-time buyers to high-end customers.
AB Tasty is a software company that specializes in experimentation, personalization, and product optimization for marketers and product teams. Founded in 2009 and headquartered in Paris, France, AB Tasty provides a cloud-based platform that enables businesses to enhance their digital assets across various industries, including e-commerce, retail, travel, luxury, and financial services. The platform offers a comprehensive suite of tools for conversion rate optimization, including A/B testing, split testing, and multivariate testing, allowing teams to modify web pages and create new designs. By helping marketing, product, and technical teams understand user behavior and engage effectively with website and mobile visitors, AB Tasty aims to convert these visitors into customers, subscribers, and leads while driving overall business growth.
RGF Group is a manufacturer specializing in plastic injection molding, catering to various sectors such as healthcare, sports, construction, home automation, automotive, and industrial equipment. The company utilizes advanced technology, including electric and hydraulic machines, to offer both single and bi-material injection solutions. In addition to manufacturing, RGF Group provides expertise in the design and production of injection tooling, ensuring high-quality and efficient service. With production facilities located in France and globally, RGF Group emphasizes flexibility and responsiveness to meet the industrial challenges of its clients.
MultiX S.A. is a French company established in 2010, specializing in the design, production, and sale of advanced spectrometric X-ray detectors. These detectors are primarily used for identifying materials across various sectors, including security, food processing, mining, recycling, and other non-destructive testing applications. MultiX's technology enhances the capabilities of system manufacturers, enabling them to significantly reduce false alarm rates in baggage screening systems at airports and other sensitive locations. This improvement allows airport operators to streamline passenger experiences by minimizing the need for travelers to remove liquids and laptops from their hand luggage, all while adhering to stringent security regulations. By providing efficient and reliable detection solutions, MultiX supports integrators in enhancing operational efficiency and passenger comfort.
OCTIMET oncology’s overall strategy is to advance the development of discovery stage molecules by employing innovative patient selection and pharmacodynamic biomarker-based strategies, as well as an innovative clinical development strategy.
Bankin' is the Best Mobile Money Manager. Bankin' app makes money management super easy. At Bankin', they believe that money management must be simple, transparent and efficient so you can focus on what really matters to you. Their mission is to bring innovation and technology together to offer you the best solution to guide you every day. They are the leader in Europe: you are more than 1.5 million to trust us in France, in England, in Spain, and in Germany. They are the only company independent of banks in Europe. It is something they feel very strongly about because it allows us to provide better guidance by always suggesting what's right for you.
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.
Ducatillon is a retailer focused on the internet distribution of breeding equipment and outdoor leisure goods, catering to hobby farmers and families with pets, poultry, rabbits, goats, and sheep. The company also offers a range of equipment and accessories tailored for hunting enthusiasts and their hunting dogs. By specializing in branded and durable products, Ducatillon aims to meet the needs of its customers in the recreational goods sector.
BIZAY operates a digital marketplace that specializes in customizable products, catering to a diverse range of customers across Europe and the Americas. The company offers the world's largest catalogue of customizable items, allowing local manufacturers, brands, and wholesalers to deliver personalized products efficiently. Its platform targets various customer segments, including B2B2C businesses, small and medium-sized enterprises, and major brands seeking customized solutions. BIZAY’s extensive offerings encompass promotional items, packaging, home and garden goods, fashion products, and beauty items. The company emphasizes sustainability and social responsibility by collaborating with partners focused on inclusion and utilizing recycled materials in production. BIZAY employs advanced supply-chain optimization technologies to significantly reduce production costs, empowering clients to enhance their marketing strategies through innovative customization options.